Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.
Expression of IL-33 and its epigenetic regulation in Multiple Sclerosis.
Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.
Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells.
[Multiple sclerosis : actuality and therapeutic prospects].
Long-term clinical and magnetic resonance imaging outcomes from patients treated with teriflunomide: Results from a phase 2 extension study.
Effects of murine and human bone marrow-derived mesenchymal stem cells on cuprizone induced demyelination.
Ophthalmic Evaluations in Clinical Studies of Fingolimod (FTY720) in Multiple Sclerosis.
Liposarcoma concurrence in a multiple sclerosis patient treated with interferon-beta 1b.
Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial.
A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis
Santhera receives first product approval: Health Canada approves Catena® for treatment of Friedreich's ataxia
Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved.
The potential role of epigenetic modifications in the heritability of multiple sclerosis.
The delta-subunit of the epithelial sodium channel (ENaC) enhances channel activity and alters proteolytic ENaC activation.
Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid.
Phenytoin (Dilantin) and acupuncture therapy in the treatment of intractable oral and facial pain.
Solitary sclerosis: Progressive neurological deficit from a spatially isolated demyelinating lesion: A further report.
MS and NMO: Partners No More.
Vinpocetine inhibits oligodendroglial precursor cell differentiation.
Dispositional optimism is unidimensional or bidimensional? The Portuguese revised Life Orientation Test.
[The influence of locomotor treatment using robotic body-weight-supported treadmill training on rehabilitation outcome of patients suffering from neurological disorders].
Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon.
Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation.
Molecular targets of FTY720 (fingolimod).

Pages